Clinical Trials Logo

Smoking clinical trials

View clinical trials related to Smoking.

Filter by:

NCT ID: NCT03015597 Completed - Smoking Cessation Clinical Trials

Pilot Study of Contingency Management for Smoking Cessation

Start date: October 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to see whether contingency management (CM) can be successfully added as an adjunct treatment to standard stop smoking services in outpatients undergoing treatment for opiate addiction. Forty tobacco smoking patients undergoing treatment for opiate addiction will be stratified to a CM intervention for either smoking abstinence or attendance at the clinic, whilst also receiving usual stop smoking services cessation treatment. The intervention will run for five weeks and participants will be followed up six months after the beginning of the study.

NCT ID: NCT03006224 Completed - Smoking Clinical Trials

The Effects of Secondary Smoking During One Lung Ventilation

Start date: December 2016
Phase: N/A
Study type: Interventional

Smoking and perhaps secondary smoking is associated with many perioperative and postoperative complications, especially respiratory events. Hypoxemia and airway damage can be associated with secondary smoking. The aim of study is to predict the incidence of hypoxemia and airway damage during one lung ventilation for lobectomy.

NCT ID: NCT02999399 Completed - Smoking Clinical Trials

Glucobrassicin-Brussel Sprout Effect on D10 Phe Metabolism

Start date: December 1, 2016
Phase: Phase 1
Study type: Interventional

To determine whether glucobrassicin-rich Brussels sprouts can favorably modify the metabolism of the polycyclic aromatic hydrocarbon deuterated phenanthrene ([D10]phe) in current and former smokers

NCT ID: NCT02991781 Completed - Asthma Clinical Trials

Combined Bio- and Neuro- Feedback vs. Varenicline Use for Smoking Cessation

Start date: January 2017
Phase: N/A
Study type: Interventional

This study will develop and experimentally test the efficiency of a neurofeedback training protocol vs. varenicline use for smoking cessation.

NCT ID: NCT02971137 Completed - Pain Clinical Trials

Pain and Smoking Study

PASS
Start date: December 22, 2017
Phase: N/A
Study type: Interventional

This purpose of this study is to test the telephone delivery of a cognitive behavioral intervention (CBI), for smoking cessation among Veteran smokers with chronic pain

NCT ID: NCT02968199 Completed - Smoking Clinical Trials

Building a Community-based Network to Promote Smoking Cessation

Start date: January 2006
Phase: N/A
Study type: Interventional

This study describes the development of a community-based network to promote smoking cessation among female smokers in Hong Kong.

NCT ID: NCT02955095 Withdrawn - Smoking Cessation Clinical Trials

Usability and Pilot Testing - Intervention for Smoking Cessation

Start date: August 2, 2018
Phase: N/A
Study type: Interventional

The purpose of the usability and pilot testing for the project "Developing a Bi-national Buddy Intervention for Smoking Cessation and Cultural Education" is to better understand how users interact with the smoking cessation app, and to improve the product based on the results. In pilot testing the smoking cessation app the investigators will examine the feasibility of our approach. The usability testing portion of the study is intended primarily to improve on the design of the smoking cessation app, and will: gather quantitative data on participant's performance, identify usability problems, and determine user satisfaction with the app. The pilot testing portion of the study will evaluate the feasibility, time, cost and statistical variability in an attempt to predict an appropriate sample size and improve upon the study design prior to performance of a full-scale research study. Objective 1:To collect quantitative data on participant's performance while using the app for smoking cessation. Objective 2:To identify problems with usability of the smoking cessation buddy app. Objective 3:To assess user satisfaction with the smoking cessation buddy app. Objective 4:To improve upon the design of the smoking cessation buddy app Objective 5:To assess the feasibility, time, cost, and statistical variability for a full-scale implementation of this study with the intervention group.

NCT ID: NCT02952703 Completed - Smoking Clinical Trials

Disseminating and Implementing a Smoking Cessation Program for Pregnant and Postpartum Women

Start date: November 2016
Phase: N/A
Study type: Interventional

This study tests whether a smoking cessation intervention for pregnant women that extends postpartum (Striving to Quit (STQ)) can be implemented and disseminated outside of the research environment that established its effectiveness (40% maintained biochemically verified 6-month abstinence). The research aim is: Is Striving to Quit more effective in achieving postpartum smoking cessation than "First Breath," the current standard of care for pregnant women in Wisconsin who smoke? 250 women will be randomized into one of two study groups. Pregnant women in Group A (n=125) will receive the existing First Breath prenatal intervention. Those in Group B (Striving to Quit (STQ), n=125) will receive all Group A interventions, plus 1 additional prenatal home visit, 3 postpartum in-home smoking cessation counseling visits, 3 postpartum phone calls, and up to an additional $100 in gift cards. The primary outcome will be biochemically confirmed smoking cessation at 6-months postpartum.

NCT ID: NCT02949648 Completed - Smoking Clinical Trials

Electronic Cigarette Use and Quitting in Youth

Start date: September 2015
Phase: N/A
Study type: Observational

A mixed method (longitudinal, trajectory and qualitative studies) to provide comprehensive evidence on the impact of e-cigarette use on smoking and quitting among smoking youth in Hong Kong.

NCT ID: NCT02945371 Completed - Smoking Clinical Trials

Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life

REV
Start date: September 2014
Phase: N/A
Study type: Interventional

Insufficient inhibitory control is one pathway through which early adversity is related to a range of problems including excessive alcohol use, tobacco use, and unhealthy eating. The proposed research leverages a neurally informed model of inhibitory control and how it can be improved to test the efficacy of a person-centered inhibitory control intervention in a sample of mid-life individuals with early adversity. The knowledge obtained by this study could be scaled into a flexible, low-cost, and wide-ranging intervention to remediate some of the effects of early adversity on inhibitory control and thus a number of prevalent health risking behaviors.